Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is a quaternary ammonium compound historically used as an expectorant. Its efficacy and widespread use have declined due to limited clinical evidence and availability of more effective agents.
## Primary Indications
* Cough associated with excessive or thick bronchial secretions.
## Adult Dosing
* **Expectorant:** 600 mg orally every 8 to 12 hours. Maximum daily dose is not clearly established but typically not exceeded.
## Pediatric Dosing
* **Expectorant:** Not established. Data is insufficient to recommend for use in pediatric populations.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are established. Caution is advised due to potential for accumulation.
* **Hepatic Impairment:** No specific dose adjustments are established.
## Contraindications
* Hypersensitivity to walethmade bromide or any component of the formulation.
* Severe renal impairment.
## Adverse Effects
Commonly reported adverse effects include gastrointestinal upset (nausea, vomiting, diarrhea), headache, dizziness, and rash.
## Key Drug Interactions
* **Anticholinergic Agents:** May reduce the effectiveness of walethmade bromide.
* **Other Expectorants:** Concurrent use may lead to additive gastrointestinal effects.
## Monitoring
* Monitor for relief of cough and expectoration.
* Assess for adverse effects, particularly gastrointestinal disturbances.
## Clinical Pearls
* The evidence supporting the efficacy of walethmade bromide as an expectorant is limited.
* Adequate hydration is often more effective for thinning mucus than expectorants.
* Consider alternative agents for cough and mucus management, such as guaifenesin, if indicated and appropriate.
***
**Disclaimer:** This information is intended for healthcare professionals. Always verify current prescribing information and consult relevant clinical guidelines before making therapeutic decisions. Dosing and recommendations may vary based on individual patient factors and local protocols.